Prenatal Testing and Newborn Screening Market Trend- Growing Inclination Towards Minimally And Non-Invasive Procedures

Increasing neonatal population across the globe, rapid advancements in testing and newborn screening techniques, and rising incidence of chromosomal defects in the newborn are some key factors expected to drive global Prenatal Testing and Newborn Screening market growth.

According to Emergen Research, the global prenatal testing and newborn screening market size was USD 4,124.3 million in 2019 and is expected to reach USD 10.85 billion in 2027 and register a steady revenue CAGR of 12.8% during the forecast period, 2020-2027.

Market Dynamics:

Prenatal testing and newborn screening are very crucial techniques commonly used for understanding valuable information about the baby’s health along with underlining risks. Prenatal testing is carried out during pregnancy for determining the likelihood of a baby having certain birth defects. These tests are performed during the first or second trimester. Newborn screening, on the other hand, is performed when the baby is 1 or 2 days old to detect and identify developmental, genetic, and metabolic disorders if any. These tests help in identifying conditions that are likely to affect child’s long-term health or survival.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Prenatal testing and newborn screening are rapidly gaining traction owing to increasing awareness about early detection, diagnosis, and treatment. Factors such as increasing prevalence of genetic and chromosomal diseases, rapid adoption of advanced testing systems in hospitals, maternity & specialty clinics, and diagnostic centers, and government initiatives to support prenatal testing and newborn screening are expected to drive global market revenue growth. In addition, increasing funds by private and public organizations, rapid adoption of advanced technologies such as Artificial Intelligence (AI) and Machine Learning (ML) in these systems, and high focus on developing more accurate and cost-effective systems are expected to fuel global market growth going ahead. 

However, lack of awareness about importance of prenatal testing and newborn screening especially in the remote areas in many countries across the globe, and insufficient funds for deploying advanced technologies are some key factors that can hamper global market growth to a certain extent during the forecast period. In addition, dearth of skilled experts to operate advanced systems and devices is also a key factor expected to restrain market growth going ahead.

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Non-invasive Segment to Register Rapid Revenue CAGR:

The non-invasive segment is expected to register rapid revenue CAGR over the forecast period. This can be attributed to rising prevalence of genetic disorders such as Patau’s syndrome, Down’s syndrome, and Edward’s syndrome, rapid adoption of advanced technologies, and high preference for non-invasive procedures due to less pain, shorter hospital stays, quick recovery time, low chances of infections and reduced blood loss. 

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

Hospitals Segment To Account for Largest Revenue Share:

The hospital segment is expected to account for largest revenue share between 2020 and 2027 owing to increasing prevalence of genetic disorders and birth defects across the globe, rising availability of advanced prenatal testing and newborn screening systems, growing demand for non-invasive procedures, and favorable reimbursement policies.  

Asia Pacific to Register Robust Revenue Growth:

Asia Pacific market revenue is expected to expand at a robust CAGR during the forecast period owing to increasing neonatal population, rising awareness about the importance of early screening and diagnosis, and increasing prevalence of genetic disorders and birth defects. In addition, rapid adoption of advanced technologies, growing awareness about genetic problems, and rising investments in R&D activities are expected to drive Asia Pacific market growth. 

Major Companies in the Market Include:

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Color Genomics
  • Edinburgh Genomics
  • Eurofins Scientific
  • Agilent Technologies
  • Illumina Inc.
  • Editas Medicine
  • Qiagen NV

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

For the purpose of this report, Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, test type, technology, instrument, end-users, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Prenatal Testing
  • Newborn Screening

Test Type Outlook (Revenue, USD Billion; 2017-2027)

  • Non-Invasive
  • Invasive

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Mass Spectrometry
  • Electrophoresis
  • Enzyme Immunoassays
  • DNA Assays

Instrument Outlook (Revenue, USD Billion; 2017-2027)

  • Ultrasonography
  • Reagent and Assay Kits
  • Tandem Quadrupole Detector
  • Incubator Shaker
  • Hearing Screen Instruments

End Users Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers

Regional Outlook (Revenue, USD Billion; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Looking to Purchase Reports in Bundle [Schedule a Call with An Analyst]@

Read Latest Reports Published by Emergen Research:

Weather Forecasting Systems Market

RNA Transcriptomics Market

Liquid Hydrogen Market

Continuous Fiber Composites Market

Fiberglass Market

Urgent Care Apps Market

Sports Technology Market

Signal Conditioning Modules Market

Micro Displays Market

Lactase Market

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Press Release Available @

Back to news